Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284337554> ?p ?o ?g. }
- W2284337554 endingPage "38" @default.
- W2284337554 startingPage "33" @default.
- W2284337554 abstract "ObjectiveThis study reports our initial experience with the Gore Hybrid Vascular Graft (GHVG; W. L. Gore & Associates, Flagstaff, Ariz) for staged hybrid open renovisceral debranching and endovascular aneurysm repair in patients affected by thoracoabdominal aortic aneurysms and pararenal abdominal aortic aneurysms (PAAAs).MethodsBetween December 2012 and December 2013, we analyzed outcomes of 13 patients who underwent open surgical debranching of renovisceral vessels for thoracoabdominal aortic aneurysm and PAAAs. All patients were considered at high risk for conventional surgery. Inclusion criterion was treatment by open surgical debranching of at least one visceral artery (renal artery, superior mesenteric artery [SMA], or celiac trunk [CT]) using the GHVG. In a second step, the aortic stent graft was implanted to exclude the aneurysm. If required, parallel grafts to the remaining visceral arteries were deployed in the same procedure. One patient had a symptomatic descending thoracic aortic aneurysm and another had a ruptured PAAA. Perioperative measured outcomes were immediate technical success rate, mortality, and morbidity. Median follow-up was 24.8 months (range, 0-15; mean, 8.2; standard deviation, 4 months).ResultsAll open surgical debranching of renovisceral vessels were completed as intended. GHVG was used to revascularize 20 visceral vessels in 13 patients with a mean of 1.54 vessels per patient. Six renal arteries (30%; 2 right and 4 left), 9 SMAs (45%), and 5 CTs (25%) were debranched. In nine of 13 (66%) patients, other renovisceral arteries were addressed with chimney/periscope, Viabahn Open Revascularization Technique, and end-to-side anastomosis. Two of 13 patients (15%) died of bowel ischemia. Neither patient had GHVG revascularization to the SMA or CT. Perioperative complications occurred in three patients (23%; 1 renal hematoma, 1 respiratory insufficiency, and 1 small-bowel ischemia related to a SMA GHVG thrombosis). At 24 months, estimated survival was 85%, and estimated primary and secondary patency were 94% and 100%, respectively.ConclusionsThis limited series extracted from a more consistent hybrid procedure experience showed a mortality rate similar to most recent reports. Technical feasibility and the short-term patency rate of the GHVG for renovisceral debranching during staged hybrid open and endovascular procedures were satisfactory. Use of GHVGs may represent a useful revascularization adjunct to minimize visceral ischemia in these challenging patients. This study reports our initial experience with the Gore Hybrid Vascular Graft (GHVG; W. L. Gore & Associates, Flagstaff, Ariz) for staged hybrid open renovisceral debranching and endovascular aneurysm repair in patients affected by thoracoabdominal aortic aneurysms and pararenal abdominal aortic aneurysms (PAAAs). Between December 2012 and December 2013, we analyzed outcomes of 13 patients who underwent open surgical debranching of renovisceral vessels for thoracoabdominal aortic aneurysm and PAAAs. All patients were considered at high risk for conventional surgery. Inclusion criterion was treatment by open surgical debranching of at least one visceral artery (renal artery, superior mesenteric artery [SMA], or celiac trunk [CT]) using the GHVG. In a second step, the aortic stent graft was implanted to exclude the aneurysm. If required, parallel grafts to the remaining visceral arteries were deployed in the same procedure. One patient had a symptomatic descending thoracic aortic aneurysm and another had a ruptured PAAA. Perioperative measured outcomes were immediate technical success rate, mortality, and morbidity. Median follow-up was 24.8 months (range, 0-15; mean, 8.2; standard deviation, 4 months). All open surgical debranching of renovisceral vessels were completed as intended. GHVG was used to revascularize 20 visceral vessels in 13 patients with a mean of 1.54 vessels per patient. Six renal arteries (30%; 2 right and 4 left), 9 SMAs (45%), and 5 CTs (25%) were debranched. In nine of 13 (66%) patients, other renovisceral arteries were addressed with chimney/periscope, Viabahn Open Revascularization Technique, and end-to-side anastomosis. Two of 13 patients (15%) died of bowel ischemia. Neither patient had GHVG revascularization to the SMA or CT. Perioperative complications occurred in three patients (23%; 1 renal hematoma, 1 respiratory insufficiency, and 1 small-bowel ischemia related to a SMA GHVG thrombosis). At 24 months, estimated survival was 85%, and estimated primary and secondary patency were 94% and 100%, respectively. This limited series extracted from a more consistent hybrid procedure experience showed a mortality rate similar to most recent reports. Technical feasibility and the short-term patency rate of the GHVG for renovisceral debranching during staged hybrid open and endovascular procedures were satisfactory. Use of GHVGs may represent a useful revascularization adjunct to minimize visceral ischemia in these challenging patients." @default.
- W2284337554 created "2016-06-24" @default.
- W2284337554 creator A5000539614 @default.
- W2284337554 creator A5014173916 @default.
- W2284337554 creator A5063849431 @default.
- W2284337554 creator A5066696252 @default.
- W2284337554 creator A5068285095 @default.
- W2284337554 creator A5069182031 @default.
- W2284337554 creator A5084182879 @default.
- W2284337554 creator A5086475928 @default.
- W2284337554 date "2016-07-01" @default.
- W2284337554 modified "2023-10-17" @default.
- W2284337554 title "The Gore Hybrid Vascular Graft in renovisceral debranching for complex aortic aneurysm repair" @default.
- W2284337554 cites W1916667495 @default.
- W2284337554 cites W1966920806 @default.
- W2284337554 cites W1975521684 @default.
- W2284337554 cites W1975994019 @default.
- W2284337554 cites W1977245235 @default.
- W2284337554 cites W1978259514 @default.
- W2284337554 cites W1982410934 @default.
- W2284337554 cites W1992503727 @default.
- W2284337554 cites W1994292534 @default.
- W2284337554 cites W2012611439 @default.
- W2284337554 cites W2028795507 @default.
- W2284337554 cites W2031802886 @default.
- W2284337554 cites W2033719730 @default.
- W2284337554 cites W2045585042 @default.
- W2284337554 cites W2045969883 @default.
- W2284337554 cites W2050571858 @default.
- W2284337554 cites W2071011318 @default.
- W2284337554 cites W2083280173 @default.
- W2284337554 cites W2094030287 @default.
- W2284337554 cites W2101786574 @default.
- W2284337554 cites W2128083311 @default.
- W2284337554 cites W2135585295 @default.
- W2284337554 cites W2144496388 @default.
- W2284337554 cites W2148213413 @default.
- W2284337554 cites W2153720774 @default.
- W2284337554 cites W2330278555 @default.
- W2284337554 cites W2334003268 @default.
- W2284337554 doi "https://doi.org/10.1016/j.jvs.2015.12.059" @default.
- W2284337554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26926940" @default.
- W2284337554 hasPublicationYear "2016" @default.
- W2284337554 type Work @default.
- W2284337554 sameAs 2284337554 @default.
- W2284337554 citedByCount "12" @default.
- W2284337554 countsByYear W22843375542017 @default.
- W2284337554 countsByYear W22843375542018 @default.
- W2284337554 countsByYear W22843375542019 @default.
- W2284337554 countsByYear W22843375542020 @default.
- W2284337554 countsByYear W22843375542021 @default.
- W2284337554 countsByYear W22843375542022 @default.
- W2284337554 crossrefType "journal-article" @default.
- W2284337554 hasAuthorship W2284337554A5000539614 @default.
- W2284337554 hasAuthorship W2284337554A5014173916 @default.
- W2284337554 hasAuthorship W2284337554A5063849431 @default.
- W2284337554 hasAuthorship W2284337554A5066696252 @default.
- W2284337554 hasAuthorship W2284337554A5068285095 @default.
- W2284337554 hasAuthorship W2284337554A5069182031 @default.
- W2284337554 hasAuthorship W2284337554A5084182879 @default.
- W2284337554 hasAuthorship W2284337554A5086475928 @default.
- W2284337554 hasBestOaLocation W22843375541 @default.
- W2284337554 hasConcept C126322002 @default.
- W2284337554 hasConcept C126838900 @default.
- W2284337554 hasConcept C141071460 @default.
- W2284337554 hasConcept C164705383 @default.
- W2284337554 hasConcept C2776098176 @default.
- W2284337554 hasConcept C2776634560 @default.
- W2284337554 hasConcept C2776820930 @default.
- W2284337554 hasConcept C2776926547 @default.
- W2284337554 hasConcept C2777323849 @default.
- W2284337554 hasConcept C2778119558 @default.
- W2284337554 hasConcept C2778583881 @default.
- W2284337554 hasConcept C2779464278 @default.
- W2284337554 hasConcept C2779980429 @default.
- W2284337554 hasConcept C2779993416 @default.
- W2284337554 hasConcept C2780091579 @default.
- W2284337554 hasConcept C2780601773 @default.
- W2284337554 hasConcept C2781046184 @default.
- W2284337554 hasConcept C31174226 @default.
- W2284337554 hasConcept C500558357 @default.
- W2284337554 hasConcept C71924100 @default.
- W2284337554 hasConcept C8443397 @default.
- W2284337554 hasConceptScore W2284337554C126322002 @default.
- W2284337554 hasConceptScore W2284337554C126838900 @default.
- W2284337554 hasConceptScore W2284337554C141071460 @default.
- W2284337554 hasConceptScore W2284337554C164705383 @default.
- W2284337554 hasConceptScore W2284337554C2776098176 @default.
- W2284337554 hasConceptScore W2284337554C2776634560 @default.
- W2284337554 hasConceptScore W2284337554C2776820930 @default.
- W2284337554 hasConceptScore W2284337554C2776926547 @default.
- W2284337554 hasConceptScore W2284337554C2777323849 @default.
- W2284337554 hasConceptScore W2284337554C2778119558 @default.
- W2284337554 hasConceptScore W2284337554C2778583881 @default.
- W2284337554 hasConceptScore W2284337554C2779464278 @default.
- W2284337554 hasConceptScore W2284337554C2779980429 @default.
- W2284337554 hasConceptScore W2284337554C2779993416 @default.
- W2284337554 hasConceptScore W2284337554C2780091579 @default.